Contents Go Main Menu Go Main Menu Go

Newsroom

Press Release

[News] HIRA, Easing Administrative Load of Hospitals via Streamlined Review Data
  • Date2025-04-23

HIRA, Easing Administrative Load of Hospitals via Streamlined Review Data

- Slashing essential review data from 430 all the way down to 221 items –

 

The Health Insurance Review & Assessment Service (HIRA), led by President Kang Jung-Gu, streamlines review data for submission from March 1, 2025 with the goal of more precise review of medical fees and lightened burden of administrative works for medical institutions.

 

Review data is an essential proof mandated by HIRA in the course of quality assessment review of claimed cost by hospitals, and medical providers hitherto have expressed over and over that the mandate is an onerous duty.

 

Thereby taking it into consideration, HIRA realigned ‘the review data list’ confined to key elements for review, going through with several discussions with internal & external medical experts from the 2nd half of 2024 to scale down & consolidate the required review list.

 

This streamlined approach drastically cut providers’ mandate of vital data for review from 430 items to as small as 221.

 

HIRA also paved the way for a better system which calls for HIRA to put the reason why it mandates additional data to providers in an effort to keep their complaint to a minimum.

 

Details of this simplified data can be seen in HIRA’s portal* for providers, with pertinent institutions soon informed of this announcement.

 

* HIRA’s portal for providers (http://biz.hira.or.kr) → notice

 

Director General of the Claims Review Administration Department of HIRA said “HIRA highly expects this realignment to sharply reduce administrative burdens carried by medical institutions, endeavoring to accomplish a better review system in future to concentrate on hospitals’ provision of quality of care to the general public via continuously active communication with medical fields.

Prev
[News] Toughening Up Target & Merit-Centered Quality Assessment
Next
[News] Publication of Review Result of the 2nd Pharmaceutical Reimbursement Evaluation Committee of 2025